Business Context and Reporting Period
This Form 8-K Current Report was filed by Neogen Corporation on August 14, 2025. The filing reports on corporate governance changes, specifically the departure of a current director and the appointment of a new director to the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statement data.
Material Changes
- Director Retirement: William T. Boehm notified the Company on August 11, 2025, of his retirement from the Board of Directors, effective when his term ends on October 23, 2025. Dr. Boehm has served since 2011 and currently chairs the Audit Committee.
- Director Appointment: On August 14, 2025, the Board appointed Avi Pelossof as a new director, effective October 24, 2025. Mr. Pelossof will serve as a Class II director.
Outlook, Commentary, and Risks
Management Commentary: The filing highlights Mr. Pelossof's extensive background, including over 25 years in the diagnostics market. He previously served as CEO and President of Immucor Inc., leading its turnaround and acquisition by Werfen in 2023, and as Global President of Infectious Disease at Alere Inc.
Compensation: Mr. Pelossof will participate in the Company's non-employee director compensation program, details of which are incorporated by reference from the 2024 Proxy Statement.
Risks and Contingencies: The filing states there are no arrangements or understandings regarding Mr. Pelossof's selection and no material interest transactions requiring disclosure under SEC rules.
Key Facts for Investor Verification
- Confirm the effective dates for the transition of board seats: October 23, 2025 (Boehm's departure) and October 24, 2025 (Pelossof's appointment).
- Review the 2024 Proxy Statement for specific details on the non-employee director compensation program applicable to the new appointee.
- Verify the impact of the leadership change on the Audit Committee, as the retiring director currently chairs this committee.